India Glycols Limited — Investor Meet, 17-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

India Glycols reported record Q3 & 9MFY26 revenue and EBITDA, showing robust financial performance. 9MFY26 revenue rose 11.4% with EBITDA up 28.9% and PAT up 23% to INR206 Cr. Potable Spirits drove growth (+17% revenue) via premiumization and market expansion. Bio-based Chemicals saw strong EBITDA growth (+26%), focusing on high-margin products and new bio-based amines. Biofuels also performed strongly (+51.2% revenue). The company significantly cut debt by INR582 Cr, reducing interest burden with further prepayments planned. Management is confident in sustained positive financial performance, emphasizing its diversified bio-based portfolio and strategic initiatives.